APOB and type 2 diabetes mellitus: Among the participants in the national Dutch screening program who underwent DNA testing for FH, those who were LDL receptor-negative mutation carriers had less T2DM (1.12%) than those who were LDL receptor-deficient (1.44%) or were carriers of apoB mutations (1.91%) [19].